Last Update 20 Aug 26
Fair value Decreased 5.24%LDOS: Defense And Edge AI Strength Will Offset Health Uncertainty
Leidos Holdings' updated analyst price target has shifted to $156.60 from $165.27 as analysts balance recent Q2 beats and higher targets from several firms with ongoing questions around Health segment pressure and medium term earnings power.
Analyst Commentary
Recent research on Leidos Holdings highlights a mixed but detailed picture for investors, with views split between those focused on Q2 execution and segment strength and those more cautious about healthcare exposure and medium term earnings power.
Bullish Takeaways
- Bullish analysts point to the Q2 beat on revenue, EBITDA and EPS as evidence that Leidos Holdings is executing against current expectations, which supports the case for higher valuation multiples at current levels.
- Several firms cite strong performances in defense, homeland and broader government services, with some seeing these segments as the main drivers of earnings resilience relative to Health related uncertainty.
- Higher price targets in the US$145 to US$170 range are often tied to views that portfolio diversification and capital allocation, including the new share repurchase program, can support shareholder returns if execution stays consistent.
- Some bullish analysts highlight bridge contracts in Health with margins above 20% along with more than 8% organic growth in the rest of the company in Q2 as supportive for medium term growth and cash generation assumptions.
Bearish Takeaways
- Bearish analysts remain focused on Health segment pressure, including normalization and competitive pressure, and see this as a key source of uncertainty for medium term earnings power and valuation support.
- Several brokers have cut price targets from prior levels as they reassess organic growth expectations and the impact of Defense Health Agency plans and Medical Disability Exams recompetes on future share and pricing power.
- Some cautious views link lower targets and downgrades to reduced organic growth forecasts and EPS revisions, with concerns that earlier expectations for outperformance in defense technology exposure may have been too optimistic.
- Neutral and Hold ratings clustered around the US$125 to US$150 target range reflect a view that Q2 execution was strong, but that compressed multiples and ongoing healthcare headwinds justify only measured upside in current valuation frameworks.
What’s in the News for Leidos Holdings
- Leidos Holdings reported Q2 2026 results with Non GAAP diluted EPS of $3.26 and revenue of $4.56b, which the company states is a 7.0% change year over year, led by $1.5b of revenue in the Intelligence & Digital segment. Management issued full year 2026 guidance for adjusted EPS of $12.20 to $12.50 and revenue of $18.20b to $18.40b. Source: company earnings release.
- The board of Leidos Holdings declared a quarterly cash dividend payable on September 30, 2026 and approved a new authorization to repurchase up to 20,000,000 shares after completing the prior program. RBC Capital Markets commented on the company’s diversified portfolio and capital allocation approach. Source: dividend and buyback announcement, RBC Capital Markets.
- Leidos Holdings outlined how its Adaptive Edge and Collaborative Autonomy Framework and Extension, or CAFE, support edge AI for missions where connectivity is limited, allowing real time AI decision making without constant cloud access. The company positions this as important for critical missions and infrastructure. Source: company edge AI commentary.
- Leidos Holdings raised its 2026 revenue guidance range to $18.20b to $18.40b, compared with the prior range of $18.00b to $18.40b, following recent contract wins and portfolio activity. Source: corporate guidance update.
- The company continued to add defense and national security work, including a contract worth up to $64.8m to modernize secure naval intelligence infrastructure and a task order with potential value of about $717m to support Air Combat Command ISR operations, alongside new missile tracking payload work with Sierra Space. Source: recent client award announcements.
Valuation Changes for Leidos Holdings
- Fair Value has fallen moderately, with the central estimate moving from $165.27 to $156.60.
- Discount Rate has eased slightly, shifting from 8.32% to 8.06%, which modestly lowers the required return used in the valuation framework.
- Revenue Growth assumption is essentially unchanged, moving marginally from 5.42% to 5.42%.
- Net Profit Margin has fallen, moving from 8.16% to 7.61%, which points to a more conservative view on future profitability for Leidos Holdings.
- Future P/E multiple has edged down, moving from 15.0x to 14.8x, which reflects a slightly lower valuation multiple applied to expected earnings.
Key Takeaways
- Expansion in government-funded projects and rising demand for advanced digital solutions are driving growth in high-margin, premium contracts across key sectors.
- Focus on AI integration, successful acquisitions, and recurring service-based revenues enhances operational efficiency, margin durability, and predictability of future earnings.
- Heavy reliance on government contracts, acquisition risks, and industry-wide margin pressures make Leidos vulnerable to revenue swings, integration challenges, and intensified competition.
Catalysts
About Leidos Holdings- Provides services and solutions for government and commercial customers in the United States and internationally.
- Leidos is positioned to benefit from increased, multi-year government funding focused on national security, defense modernization, border protection, and infrastructure, particularly through the One Big Beautiful Bill and related initiatives (e.g., FAA air traffic modernization, Golden Dome, maritime autonomy), which are expected to drive robust future revenue growth across core projects.
- Accelerating customer demand for digital modernization, AI-powered solutions, and autonomous systems-in defense, healthcare, and intelligence-plays to Leidos' strengths and is leading to higher-quality, higher-margin contracts that improve net margins, as these capabilities command premium pricing and are in areas of secular growth.
- Leidos' continued integration of advanced ai/automation within internal operations and customer offerings is yielding substantial sustained improvement in efficiency (lower indirect costs, faster product delivery), which is expected to support durable margin expansion and enhanced earnings.
- The successful integration of recent acquisitions (e.g., Kudu Dynamics, Dynetics) has unlocked access to $400M+ in pipeline opportunities and improved win probability on ~$2B in bids, supporting incremental revenue and increased earnings accretion over the mid-term.
- The business mix is shifting towards recurring, service-based and software-driven revenue streams (logistics, health IT, cloud-native platforms), enhancing earnings visibility and stability, which is expected to support higher long-term valuation multiples as the market recognizes improved predictability in cash flow and profit growth.
Leidos Holdings Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Leidos Holdings's revenue will grow by 5.4% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 7.8% today to 7.6% in 3 years time.
- Analysts expect earnings to reach $1.6 billion (and earnings per share of $13.58) by about August 2029, up from $1.4 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $1.9 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.9x on those 2029 earnings, up from 13.3x today. This future PE is lower than the current PE for the US Professional Services industry at 22.3x.
- Analysts expect the number of shares outstanding to decline by 1.85% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.06%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Overreliance on U.S. federal government funding-especially for defense, homeland security, and health contracts-exposes Leidos to political and fiscal risks; changes in administration priorities or reductions in government spending could cause unpredictable revenue swings and slow top-line growth.
- Heightened industry competition, including aggressive moves by large peers and non-traditional tech firms for AI-driven, outcome-based contracts, raises the risk of increased market share pressure and margin compression as procurement processes consolidate and government clients favor commercial solutions.
- Ongoing dependence on acquisitions (e.g., recent Kudu integration, prior Dynetics challenges) introduces integration risk; failure to realize anticipated synergies or manage operational complexity could erode net margins and dampen sustainable earnings growth.
- Accelerating automation and internal AI adoption-aimed at driving efficiency and reducing labor costs-may reduce the need for traditional manpower-based services over time, potentially leading to a decline in core service demand, revenue instability, and uncertainty in the sustainability of recent margin gains.
- Industry-wide price pressure and potential commoditization of IT and engineering services, as governments pursue cost efficiencies (e.g., "DOGE" initiatives, contract scope reductions, and low-margin hardware/software pass-throughs), could squeeze Leidos' profitability and limit future net margin expansion despite recent cost-saving measures.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $156.6 for Leidos Holdings based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $225.0, and the most bearish reporting a price target of just $125.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $20.7 billion, earnings will come to $1.6 billion, and it would be trading on a PE ratio of 14.9x, assuming you use a discount rate of 8.1%.
- Given the current share price of $146.31, the analyst price target of $156.6 is 6.6% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Leidos Holdings?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.